US EditionPublished • loading... • Updated
Questions swirl after Trump’s GLP-1 pricing deal announcement
The Trump administration set new prices as low as $150 for future GLP-1 pills, aiming to reduce costs despite concerns about federal coverage losses.
Summary by Ars Technica
3 Articles
3 Articles
Will Americans really lose '125 million pounds' from Trump's GLP-1 deal?
President Donald Trump announced Thursday that two major drugmakers had agreed to lower the price of popular GLP-1 medications for weight loss. Eli Lilly dropped its price for Zepbound from $1,080 for a month’s supply to $346 per month, while Novo Nordisk’s Wegovy will now cost Americans $250 per month, down from $1,350, Trump said in the Oval Office. Robert F. Kennedy Jr., secretary of the Department of Health and Human Services, and Dr. Mehme…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
